Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-014509
Filing Date
2022-03-23
Accepted
2022-03-23 16:35:02
Documents
1
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5990
  Complete submission text file 0001213900-22-014509.txt   7328
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address THE OAK, WLX ROAD BEAUMONT X0 CO16 0AT
Business Address
Lowdell Mark William (Reporting) CIK: 0001767037 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38793 | Film No.: 22763604